Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_213655.5(WNK1):c.-203C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000198 in 504,876 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
WNK1 (HGNC:14540): (WNK lysine deficient protein kinase 1) This gene encodes a member of the WNK subfamily of serine/threonine protein kinases. The encoded protein may be a key regulator of blood pressure by controlling the transport of sodium and chloride ions. Mutations in this gene have been associated with pseudohypoaldosteronism type II and hereditary sensory neuropathy type II. Alternatively spliced transcript variants encoding different isoforms have been described but the full-length nature of all of them has yet to be determined.[provided by RefSeq, May 2010]
WNK1 Gene-Disease associations (from GenCC):
neuropathy, hereditary sensory and autonomic, type 2A
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
11756
American (AMR)
AF:
0.00
AC:
0
AN:
17456
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
13394
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29690
South Asian (SAS)
AF:
0.00
AC:
0
AN:
46060
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
29580
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2072
European-Non Finnish (NFE)
AF:
0.00000305
AC:
1
AN:
327446
Other (OTH)
AF:
0.00
AC:
0
AN:
27422
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.